汉字News

← 汉字News
Chinese News for Learners
life
shēng huó
生活
·HSK 5

USA
měiguó
美国
FDA
shíyào
食药
administration
jiānguǎn
监管
bureau
approves
pīzhǔn
批准
new
xīnxíng
新型
diabetes
tángniaobìng
糖尿病
drug
yaowu
药物

USA
měiguó
美国
food
shípǐn
食品
drug
yaopin
药品
administration
jiānguǎn
监管
agency
approved
pīzhǔn
批准
a
yì zhǒng
一种
new
xīnxíng
新型
immune
miǎnyì
免疫
therapy
liaofǎ
疗法
treat
zhìliào
治疗
type 1
1 xíng
1型
diabetes
tángniaobìng
糖尿病

June 25, 2026 at 8:47 PM

USA
měiguó
美国
food
shípǐn
食品
drug
yaopin
药品
administration
jiānguǎn
监管
agency
in
zài
June
6 yue
6月
12th
12 ri
12日
approved
pīzhǔn
批准
accelerated
jiāsù
加速
teplizumab
tèpu
特普
monoclonal antibody
dan kang
单抗
this
zhè
is
shì
first
dì yī zhǒng
第一种
approved
huòpi
获批
DE
de
disease
jibing
疾病
modifying
xiūshi
修饰
therapy
liaofǎ
疗法
for
yòngyú
用于
newly diagnosed
xīn zhenduàn
新诊断
stage 3
3 qi
3期
type 1
1 xíng
1型
diabetes
tángniaobìng
糖尿病
patients
huanzhe
患者
the
gāi
drug
yaowu
药物
targets
baoxiang
靶向
acts on
zuoyong yu
作用于
immune
miǎnyì
免疫
system
xìtǒng
系统
clinical
linchang
临床
trial
shiyan
试验
demonstrated
zhengshi
证实
the
gāi
therapy
liaofǎ
疗法
can
ke
delay
yanhuan
延缓
patient
huanzhe
患者
pancreatic
yandao
胰岛
insulin
su
secretion
fenmi
分泌
decline
xiajiang
下降
this
zhè
CL
xiàng
approval
pīzhǔn
批准
represents
daibiao
代表
PERF
le
diabetes
tángniaobìng
糖尿病
treatment
zhìliào
治疗
field
lǐngyù
领域
DE
de
significant
zhongda
重大
progress
jinzhan
进展

New Words

dan kelonkang tǐ
单克隆抗体
monoclonal antibody
1 xing tangniao bing
1型糖尿病
type 1 diabetes
mianyì xìtǒng
免疫系统
immune system
yandao su
胰岛素
insulin
jiāsù pizhun
加速批准
accelerated approval
linchang shiyan
临床试验
clinical trial
jibing xiushi
疾病修饰
disease-modifying
xin zhenduàn
新诊断
newly diagnosed
jinzhan
进展
progression
xibao
细胞
cell

News in English

Lifestyle & Culture

FDA Approves Teplizumab to Delay Type 1 Diabetes Progression in Children

The US Food and Drug Administration approved teplizumab on June 12, offering accelerated approval to delay the decline in insulin production in children aged 8 to 17 recently diagnosed with type 1 diabetes.

The US Food and Drug Administration approved teplizumab on June 12, granting accelerated approval to delay the decline in insulin production in children aged 8 to 17 who have recently been diagnosed with stage 3 type 1 diabetes. This marks the first disease-modifying therapy cleared for new-onset stage 3 disease in this age group. Teplizumab is a monoclonal antibody that targets the immune system to slow down the destruction of insulin-producing beta cells in the pancreas. Clinical trials demonstrated that the therapy could significantly delay the progression to insulin dependence in newly diagnosed patients. This approval represents a major breakthrough in type 1 diabetes treatment, offering hope to young patients and their families for slowing disease progression.

More in Lifestyle & Culture

the Arctic / Arctic
Běijí
北极
permafrost
yǒngjiǔ dòng tǔ
永久冻土
to accelerate / to speed up
jiāsù
加速
to melt / to thaw
rónghuà
融化
ancient / age-old
gǔlǎo
古老
organic carbon
yǒujī tàn
有机碳
to flow into
liúrù
流入
ocean / sea
hǎiyáng
海洋
to raise / to trigger
yǐnfā
引发
climate
qìhòu
气候
warning / alert
jǐngshì
警示

Thawing Arctic Permafrost Releases Ancient Carbon Into Oceans, Raising Climate Fears

new
xīnxíng
新型
wearable
kěchuāndài
可穿戴
patch
tiēpiàn
贴片
accelerate
jiāokuài
加快
people
rénmen
人们
enter
jìnrù
进入
deep
shēndù
深度
sleep
shuìmián
睡眠

New Wearable Patch Accelerates Entry Into REM Sleep by 43 Minutes

total solar eclipse
rìquánshí
日全食
today
jīnrì
今日
to cross / to pass through
chuānyuè
穿越
Iceland
Bīngdǎo
冰岛
and
Spain
Xībānyá
西班牙

Total Solar Eclipse Crosses Iceland and Spain Today

China
Zhōng guó
中国
to be unearthed / to excavate
chū tǔ
出土
the Warring States period
Zhàn guó
战国
bronze
qīng tóng
青铜
wine vessel
jiǔ qì
酒器
containing inside
nèi cáng
内藏
dating back from now
jù jīn
距今
approximately
yuē
2,300 years
2300 nián
2300年
(modifier particle)
de
ancient
gǔ dài
古代
fine wine
měi jiǔ
美酒

Warring States Bronze Vessel Containing 2,300-Year-Old Wine Unearthed in China